跳至主要内容
临床试验/EUCTR2009-011682-91-IT
EUCTR2009-011682-91-IT进行中(未招募)不适用

Role of 64Cu-ATSM PET/CT for the localization of hypoxic areas in uterine cervical cancer - 64Cu-ATSM-UTERO-01/2009

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点目标入组 30 人开始时间: 2009年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1. adult women (age >18years) 2. patients diagnosed with uterine cervical cancer (stage II and III) and scheduled for radiation therapy as the only treatment. 3. no previous chemiotherapy treatment before enrollment 4. signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. patients diagnosed with uterine cervical cancer and scheduled for radiation therapy as the only treatment. 2. adult women (age >18years) 3. signed informed consent

研究者

发起方
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

相似试验

进行中(未招募)
不适用
Role of 64Cu-ATSM PET/CT for the localization of hypoxic areas in head and neck cancer - 64-Cu-ATSM-CC-02/2009head and neck cancer. MEDRA code has not been found.MedDRA version: 9.1Level: LLTClassification code 10026184MedDRA version: 9.1Level: LLTClassification code 10026161MedDRA version: 9.1Level: LLTClassification code 10025963MedDRA version: 9.1Level: LLTClassification code 10025923
EUCTR2009-012225-12-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI30
进行中(未招募)
1 期
se of the diagnostic PET with 64CuCl2 in order to select patients, in which a disease relapse is shown after prostate surgical removal, to be successfully treated to radiation therapy on the prostate bedcancer on the prostatic bedMedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-004332-11-ITSPARKLE SR138
尚未招募
不适用
64CuATSM Positron Emission Tomography with Quantitative Susceptibility Mapping Magnetic Resonance Imaging as a Biomarker of Motor Neurone Diseasemotor neurone diseaseNeurological - Neurodegenerative diseases
ACTRN12623000067673Florey Institute of Neuroscience and Mental Health15
进行中(未招募)
1 期
64Cu-DOTATATE PET/CT-skanning to diagnose infection in the heart valvesInfective endocarditis
EUCTR2021-005501-27-DKRigshospitalet65
进行中(未招募)
1 期
Diagnostic-predictive value of copper-64 dichloride in bladder cancer patients eligible for chemotherapybladder cancer patients eligible for cisplatin chemotherapyMedDRA version: 20.0Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2019-002534-37-ITENTE OSPEDALIERO OSPEDALI GALLIERA50